Nitrogenous Compounds from the Antarctic Fungus Pseudogymnoascus sp. HSX2#-11

Area of Science:

• Mycology
• Natural Product Chemistry
• Antarctic Biology

Background:

• The fungal genus Pseudogymnoascus comprises psychrophilic (cold-loving) and pathogenic species widely found in Antarctica.
• Research into the secondary metabolites of Pseudogymnoascus species, particularly those from Antarctic environments, is notably limited.
• Antarctic fungi are a potential source of novel bioactive compounds due to unique evolutionary pressures.

Purpose of the Study:

• To systematically investigate the secondary metabolites produced by the Antarctic fungus Pseudogymnoascus sp. HSX2#-11.
• To isolate and characterize novel chemical compounds from this understudied fungal species.
• To report for the first time the presence of pyridine, pyrimidine, and diketopiperazine classes of compounds within the Pseudogymnoascus genus.

Main Methods:

• Isolation of metabolites from fungal cultures of Pseudogymnoascus sp. HSX2#-11.
• Extensive spectroscopic analysis (e.g., NMR, Mass Spectrometry) for structure elucidation.
• Comparison of spectral data with existing literature to identify known and novel compounds.

Main Results:

• One new pyridine derivative, 4-(2-methoxycarbonyl-ethyl)-pyridine-2-carboxylic acid methyl ester, was isolated and characterized.
• Thymine, a common pyrimidine base, was identified.
• Eight diketopiperazines were identified: cyclo-(dehydroAla-l-Val), cyclo-(dehydroAla-l-Ile), cyclo-(dehydroAla-l-Leu), cyclo-(dehydroAla-l-Phe), cyclo-(l-Val-l-Phe), cyclo-(l-Leu-l-Phe), cyclo-(l-Trp-l-Ile), and cyclo-(l-Trp-l-Phe).

Conclusions:

• This research represents the first report of pyridine, pyrimidine, and diketopiperazine compounds isolated from the genus Pseudogymnoascus.
• The findings expand the known chemical diversity of secondary metabolites from Antarctic fungi.
• The characterized compounds provide a basis for further investigation into their biological activities and potential applications.